Evidence map›Paper›PMID 32054081›Full record

ReviewAnimals : an open access journal from MDPI2020

Application of

Leonid Ushanov, Besarion Lasareishvili, Irakli Janashia, Andreas E Zautner

Abstract readReview
In one paragraph

Review in Animals : an open access journal from MDPI, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Characterization and application of a novelCurrent research in food science · 2025
    Article
  8. Article
  9. Article
  10. Microbiology spectrum · 2024
    Article
  11. Review
  12. Role of Bacteriophages for Optimized Health and Production of Poultry.Animals : an open access journal from MDPI · 2022
    Review
  13. Microorganisms · 2022
    Review
  14. From Farm to Fork:Viruses · 2022
    Review
  15. Review
  16. Antibiotics (Basel, Switzerland) · 2022
    Article
  17. Distribution of CRISPR Types in Fluoroquinolone-ResistantPathogens (Basel, Switzerland) · 2021
    Article
  18. Application of Bacteriophages to LimitFrontiers in microbiology · 2021
    Review
  19. Isolation and Characterization of Group IIIFrontiers in microbiology · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Leonid UshanovInstitute of Veterinary Medicine, Agricultural University of Georgia, 0159 Tbilisi, Georgia.
Besarion LasareishviliInstitute of Veterinary Medicine, Agricultural University of Georgia, 0159 Tbilisi, Georgia.
Irakli JanashiaInstitute of Entomology, Agricultural University of Georgia, 0159 Tbilisi, Georgia.
Andreas E ZautnerInstitute of Medical Microbiology, University Medical Center Göttingen, 37075 Göttingen, Germany.

Funding

Deutsche Forschungsgemeinschaft ZA 697/6-1
6 · The paper itself

Abstract

Bacteriophages (phages) are the most abundant and diverse biological entities in the biosphere. Due to the rise of multi-drug resistant bacterial strains during the past decade, phages are currently experiencing a renewed interest. Bacteriophages and their derivatives are being actively researched for their potential in the medical and biotechnology fields. Phage applications targeting pathogenic food-borne bacteria are currently being utilized for decontamination and therapy of live farm animals and as a biocontrol measure at the post-harvest level. For this indication, the United States Food and Drug Administration (FDA) has approved several phage products targeting

Indexed as

bacteriophageCampylobacter phagesC. jejuniphage-based applicationsphage therapy

Identifiers

PMID32054081
PMCPMC7070343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.